NEW YORK (TheStreet) -- RATINGS CHANGES

 
Franklin Resources ( BEN - Get Report) was upgraded from Hold to Buy, Deutsche Bank said. Stock has pulled back to an attractive level. $46 price target. 
 
BofNY Mellon ( BK - Get Report)  was upgraded from Hold to Buy, Deutsche Bank said. Valuation call, based on a $47 price target. 

Ciena ( CIEN - Get Report)  was upgraded to Outperform, RBC Capital said. $28 price target. Company deserves a higher multiple, as margins and cash flow will likely improve in the near term. 
 
Fitbit ( FIT - Get Report) coverage was started with an Outperform rating, FBN Securities said. $50 price target. Company is the leader in a market that can grow 49% annually through the end of the decade. 

Finisar ( FNSR) was downgraded to Sector Perform, RBC Capital said. $17 price target. Company lacks near-term catalysts. 

Mannkind ( MNKD - Get Report)  was downgraded from Neutral to Underweight, Piper Jaffray said. Afrezza launch has been lackluster. $1.50 price target. 
 
Micron ( MU - Get Report)  was initiated with a Buy rating, Sterne Agee said. $23 price target. Company's technology position is improving. 

Ryder ( R - Get Report)  was cut to Sector Weight, Keybanc said. Modertaing used truck prices could be a headwind. 
 
SolarCity ( SCTY) rated new Outperform at Oppenheimer. $66 price target. Company has significan scale advantages and North America should drive growth in the coming quarters. 

Terex ( TEX - Get Report)  was downgraded from Neutral to Underweight, JP Morgan said. $23 price target. Expect few benefits from the pending merger. 
 
Tesla ( TSLA - Get Report) was initiated with an Outperform rating, Oppenheimer said. $340 price target. Company has a transformative product with leading expertise. 
 
Tetraphase ( TTPH - Get Report) downgraded at Wedbush from Outperform to Neutral, Wedbush said. $11 price target. Market opportunity is now in question for Eravacycline.
Tetraphase ( TTPH - Get Report) was downgraded at Cantor to Hold. $11 price target. Eravacycline lacks visibility for regualtory approval. 

Stock Comments / EPS Changes

 
Alibaba ( BABA - Get Report) estimates, target cut at Cantor. Shares of BABA now seen reaching $88, according to Cantor Fitzgerald. Estimates also reduced, given macro weakness in China. Buy rating. 
 
Dollar General ( DG - Get Report) numbers cut at Citi. Shares of DG now seen reaching $85, according to Citigroup. Estimates also reduced, given the company's new guidance. Buy rating.